Literature DB >> 8930820

Performance of a computer simulated neural network trained to categorise normal, premalignant and malignant oral smears.

M R Brickley1, J G Cowpe, J P Shepherd.   

Abstract

The accurate detection of malignant neoplasms whilst they are still small is recognised as one of the main factors increasing chances of survival. Neural networks have many biomedical applications and they have been applied to neoplasia but their use in oral pathology has only recently been documented. The objectives of this study were to train networks to discriminate between normal and dysplastic mucosa. Each network was trained by back propagation, internal cross validation and tested on additional data. The data were derived by analysing 348 intra-oral smears and included mean nuclear and mean cytoplasmic areas of the smears measured by image analysis. A neural network differentiated between normal/non-dysplastic mucosa and dysplastic/malignant mucosa (specificity 0.82, sensitivity 0.76). These early results suggest that integrating neural networks and image analysis, as well as investigating additional criteria, could enhance automation and accuracy of smear techniques in diagnosing oral malignancy.

Entities:  

Mesh:

Year:  1996        PMID: 8930820     DOI: 10.1111/j.1600-0714.1996.tb00291.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  3 in total

1.  [Noninvasive brush biopsy as an innovative tool for early detection of oral carcinomas].

Authors:  T W Remmerbach; S N Mathes; H Weidenbach; A Hemprich; A Böcking
Journal:  Mund Kiefer Gesichtschir       Date:  2004-03-17

2.  Computerized morphometric discrimination between normal and tumoral cells in oral smears.

Authors:  Irina-Draga Caruntu; Monica M Scutariu; Gioconda Dobrescu
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

Review 3.  The contribution of artificial intelligence to reducing the diagnostic delay in oral cancer.

Authors:  Betul Ilhan; Pelin Guneri; Petra Wilder-Smith
Journal:  Oral Oncol       Date:  2021-03-09       Impact factor: 5.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.